•Noninjection routes for immunotherapy Giorgio W. Canonica, MD, and Giovanni Passalacqua, MD, Genoa, Italy
•Airway remodeling in asthma—new insights Donna E. Davies, PhD, James Wicks, BSc, Robert M. Powell, PhD, Sarah M. Puddicombe, PhD, and Stephen T. Holgate, MD, DSc, Southampton, United Kingdom
•Chemokines in asthma: Cooperative interaction between chemokines and IL-13 Nives Zimmermann, MD, Gurjit K. Hershey, MD, PhD, Paul S. Foster, PhD, and Marc E. Rothenberg, MD, PhD, Cincinnati, Ohio, and Canberra, Australia
•The antiallergic drug oxatomide promotes human eosinophil apoptosis and suppresses IL-5–induced eosinophil survival Mariko Domae, PhD, Hironori Sagara, MD, PhD, Morito Sakaue, PhD, Takeshi Fukuda, MD, PhD, and Yuichiro Kamikawa, PhD, Tochigi, Japan
•Cysteinyl leukotriene expression in chronic hyperplastic sinusitis/nasal polyposis: Importance to eosinophilia and asthma among the authors: John W. Steinke, PhD, Dewayne Bradley, MD, Pablo Arango, MD, Stilianos E. Kountakis, MD, Monica Kraft, MD, and Larry Borish, MD, Charlottesville, Va, and Denver, Colo
•Circadian variation of sputum inflammatory cells in mild asthma Sarah E. Panzer, BS, Ann M. Dodge, BSN, Elizabeth A. B. Kelly, PhD, and Nizar N. Jarjour, MD, Madison, Wis
•Preconception maternal immunization to dust mite inhibits type I hypersensitivity response of offspring Jefferson R. Victor, Jr, BSc, Ana E. Fusaro, PharmD, Alberto J. da Silva Duarte, MD, PhD, and Maria N. Sato, PhD, São Paulo, Brazil
•Direct costs of allergic rhinitis in the United States: Estimates from the 1996 Medical Expenditure Panel Survey Amy W. Law, PharmD, Shelby D. Reed, PhD, John S. Sundy, MD, PhD, and Kevin A. Schulman, MD, Durham, NC
•Efficacy of liposomal budesonide in experimental asthma among the authors: Kameswari S. Konduri, MD, Sandhya Nandedkar, PhD, Nejat Düzgünes, PhD, James Artwohl, DVM, Ralph Bunte, DVM, and Pattisapu R. J. Gangadharam, PhD, Milwaukee, Wis, San Francisco, Calif, and Chicago, Ill
•Differences in fecal microflora between patients with atopic dermatitis and healthy controls among the authors: Shinichi Watanabe, MD, Yutaka Narisawa, MD, Hiroshi Okamatsu, MSc, Takeshi Ikenaga, MSc, Yoshito Taziri, MSc, and Megumi Kumemura, MSc, Toyko, Saga, Tokushima, and Siga, Japan
•Effect of probiotic lactobacillus strains in children with atopic dermatitis among the authors: Vibeke Rosenfeldt, MD, PhD, Eva Benfeldt, MD, PhD, Susanne D. Nielsen, MD, DMSc, Dorthe L. Jeppesen, MD, PhD, Niels H. Valerius, MD, DMSc, and Anders Paerregaard, MD, DMSc, Copenhagen and Hvidovre, Denmark
•Long-term assessment of T-cell populations in DiGeorge syndrome Javier Chinen, MD, PhD, Howard M. Rosenblatt, MD, E. O'Brian Smith, PhD, William T. Shearer, MD, PhD, and Lenora M. Noroski, MD, Houston, Tex
